Cite
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV.
MLA
Lee, Yu-Lin, et al. “Dual Therapy with Dolutegravir plus Boosted Protease Inhibitor as Maintenance or Salvage Therapy in Highly Experienced People Living with HIV.” International Journal of Antimicrobial Agents, vol. 58, no. 3, Sept. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ijantimicag.2021.106403.
APA
Lee, Y.-L., Lin, K.-Y., Cheng, S.-H., Lu, P.-L., Wang, N.-C., Ho, M.-W., Yang, C.-J., Liou, B.-H., Tang, H.-J., Huang, S.-S., Huang, S.-H., Chen, T.-C., Lin, C.-Y., Lin, S.-P., Lee, Y.-T., & Hung, C.-C. (2021). Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV. International Journal of Antimicrobial Agents, 58(3), N.PAG. https://doi.org/10.1016/j.ijantimicag.2021.106403
Chicago
Lee, Yu-Lin, Kuan-Yin Lin, Shu-Hsing Cheng, Po-Liang Lu, Ning-Chi Wang, Mao-Wang Ho, Chia-Jui Yang, et al. 2021. “Dual Therapy with Dolutegravir plus Boosted Protease Inhibitor as Maintenance or Salvage Therapy in Highly Experienced People Living with HIV.” International Journal of Antimicrobial Agents 58 (3): N.PAG. doi:10.1016/j.ijantimicag.2021.106403.